Evidence map›Paper›PMID 40184501›Full record

ArticleThe Journal of infectious diseases2025

Epidemiological and Clinical Insights into Enterovirus Circulation in Europe, 2018-2023: A Multicenter Retrospective Surveillance Study.

Sten de Schrijver, Emiel Vanhulle, Anne Ingenbleek, Leonidas Alexakis, Caroline Klint Johannesen, Eeva K Broberg, Heli Harvala, Thea K Fischer, Kimberley S M Benschop, ENPEN Study Collaborators

Abstract readMulticenter Study
In one paragraph

Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sten de SchrijverCentre for Infectious Disease Control, Dutch National Public Health Institute, Bilthoven, The Netherlands.ORCID 0009-0006-5143-9138
Emiel VanhulleCentre for Infectious Disease Control, Dutch National Public Health Institute, Bilthoven, The Netherlands.ORCID 0000-0002-5483-6925
Anne IngenbleekEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Leonidas AlexakisEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Caroline Klint JohannesenDepartment of Clinical Research, Nordsjællands Hospital, Hillerød, Denmark.ORCID 0000-0001-6503-5632
Eeva K BrobergEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Heli HarvalaNational Health Service Blood and Transplant, Microbiology Services, Colindale, United Kingdom.ORCID 0000-0001-9154-4190
Thea K FischerDepartment of Clinical Research, Nordsjællands Hospital, Hillerød, Denmark.ORCID 0000-0003-4812-980X
Kimberley S M BenschopCentre for Infectious Disease Control, Dutch National Public Health Institute, Bilthoven, The Netherlands.ORCID 0000-0002-8328-0882
ENPEN Study Collaborators

Funding

Clinical Virology NetworkEuropean Centre for Disease Prevention and ControlFrench National Public Health NetworkHUS Diagnostic Center TYH2024104Instituto de Salud Carlos III PI18CIII/00017Instituto de Salud Carlos III PI22CIII/00035Santé Publique France
6 · The paper itself

Abstract

backgroundEnteroviruses (EV) cause yearly outbreaks with severe infections, particularly in young children. This study investigates EV circulation, age, and clinical presentations in Europe from 2018 to 2023.

methodsAggregated data were requested from the European Centre for Disease Prevention and Control National Focal Points for Surveillance and European Non-Polio Enterovirus Network. Data included detection month, specimen type, age group, and clinical presentation for the 10 most commonly reported EV types per year.

resultsTwenty-eight institutions (16 countries) reported 563 654 EV tests during the study period with 33 265 (5.9%) EV positive. Forty-two types were identified (n = 11 605 cases) with echovirus 30 (E30), coxsackievirus A6 (CVA6), EV-D68, E9, E11, CVB5, E18, CVB4, EV-A71, and E6 most frequently reported. E30 declined after 2018/2019, while CVA6, CVB5, E9, E11, and EV-D68 were prevalent both before and after the coronavirus disease 2019 (COVID-19) pandemic, and CVB4 and E18 were prevalent after the pandemic. A shift in seasons (summer to fall) and specimen positivity (feces to respiratory) was observed. Neurological signs predominated among EV-A71, CVB4, CVB5, E6, E9, E11, E18, and E30 (30%-72%). CVB4, CVB5, E9, E11, and E18 were frequently reported among neonates (18%-32%). CVA6 was frequently associated with hand, foot and mouth disease, and EV-D68 with respiratory infections. Paralysis was reported among 22 infections, associated with 10 nonpolio types.

conclusionsThis study emphasizes the widespread circulation and severity of EV infections in Europe, as well as the (re)emergence of specific types postpandemic. Our findings highlight the need for continuous EV surveillance to monitor variation in circulation, age, and clinical presentations, including paralysis among nonpolio EV infections.

Indexed as

EnterovirusEnterovirus InfectionsAdolescentAdultAgedChildChild, PreschoolCOVID-19Epidemiological MonitoringEuropeFemaleHumansInfantInfant, NewbornMaleMiddle AgedenterovirusepidemiologyEuropelaboratory detectionsurveillance

Identifiers

PMID40184501
PMCPMC12308651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.